Machaon Diagnostics

Executive Summary

Machaon Diagnostics is a specialized reference laboratory and clinical trial service provider based in Berkeley, California. Founded in 2015, the company focuses on advanced diagnostics in coagulation, platelet disorders, complement system, hyperinflammatory conditions, and genetics. It offers a comprehensive test directory, sponsored testing programs, and central laboratory services for clinical trials. Despite operating at a pre-clinical stage, Machaon has established a niche in complex hematology and immunology testing, serving both clinical and research customers. With the growing demand for precision diagnostics and decentralized clinical trials, Machaon is well-positioned to expand its market share. However, the company remains private with no disclosed funding, and its profile is relatively low, limiting visibility. Its success hinges on continued innovation in test menu expansion and forging partnerships with biopharma sponsors.

Upcoming Catalysts (preview)

• Q3 2026Launch of new hyperinflammatory panel including IL-6 and ferritin70% success
• TBDPartnership with a major CRO for central lab services50% success
• Q1 2027FDA clearance for a novel complement diagnostic assay40% success